Skip to main content
Defiance International

Study type: Human research · Status: Evidence verified by machine against declared source

Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study.

Scientific reports · 2022

Study scale: Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Abstract only: Open source record

Product or molecular entity relationships

  • Humanin: Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Public plain-language summary

Some fields are not published, because the text held for them did not answer their heading. The published text is limited to the declared source and preserves reported uncertainty. It does not establish efficacy, safety, suitability, or evidence strength.

Research question

Not reported in the declared source.

Study design

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Participants or experimental system

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Study scale

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Intervention or exposure

The exclusion criteria were as follows: (1) patients with COPD exacerbation 8 weeks prior to inclusion in the study, (2) patients receiving treatment with pulmonary rehabilitation during the study or 6 months before the inclusion period, (3) patients with a previous diagnosis of coronary artery disease, heart failure, patients with respiratory diseases different from COPD, rheumatological diseases or cancer, (4) patients with C-reactive protein levels higher than 2.5 mg/dL or elevated creatine kinase levels and (5) patients with a glomerular filtration rate < 50 mL/min/1.73 m2.

Comparator

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Outcomes examined

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Key findings

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Limitations and uncertainty

Not published. The text held for this field did not answer this heading, so nothing is shown here and nothing is substituted for it.

Product relevance and evidence boundary

This record is a published study, held here with its citation and review status. It is not a statement that any catalog item is effective, safe, or suitable for any use, and nothing in it is a dose or a protocol.

Evidence verified by machine against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.